The Brazilian billionaire Foundation Jorge Lehmann and other commercial enterprises intend to finance the construction of a plant to produce a vaccine for Covid-19, caused by the emerging corona virus, to be developed by the University of Oxford and the pharmaceutical company AstraZeneca.
The Lehman Foundation said in a statement on Friday that the plant has cost 100 million Brazilian reals ($ 18 million) and will be donated to the most important biomedical research and development laboratory in Brazil, the Oswaldo Cross Foundation, also known as Viocross.
She added that the plant will be ready to produce 30 million doses of vaccine per month from the beginning of 2021.
The number of Covid-19 deaths in Brazil is approaching 100,000, in the worst outbreak of the Corona virus in the world after the United States.
The Brazilian government believes that the British vaccine is the most promising vaccine that researchers are developing around the world.
The Oxford / AstraZeneca vaccine is being tested on Brazilian volunteers in a study led by the Federal University of São Paulo, also funded by the Lyman Foundation.